These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [3H]GBR-12935 binding to human cerebral cortex is not to dopamine uptake sites. Allard P, Danielsson M, Papworth K, Marcusson JO. J Neurochem; 1994 Jan; 62(1):338-41. PubMed ID: 8263533 [Abstract] [Full Text] [Related]
48. [3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. Schweri MM, Skolnick P, Rafferty MF, Rice KC, Janowsky AJ, Paul SM. J Neurochem; 1985 Oct; 45(4):1062-70. PubMed ID: 4031878 [Abstract] [Full Text] [Related]
49. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. Vaugeois JM, Bonnet JJ, Duterte-Boucher D, Costentin J. Eur J Pharmacol; 1993 Jan 12; 230(2):195-201. PubMed ID: 8422901 [Abstract] [Full Text] [Related]
50. Imaging the dopamine uptake site with ex vivo [18F]GBR 13119 binding autoradiography in rat brain. Ciliax BJ, Kilbourn MR, Haka MS, Penney JB. J Neurochem; 1990 Aug 12; 55(2):619-23. PubMed ID: 2115074 [Abstract] [Full Text] [Related]
51. [3H]GBR 12935 binding to dopamine uptake sites in the human brain. De Keyser J, De Backer JP, Ebinger G, Vauquelin G. J Neurochem; 1989 Nov 12; 53(5):1400-4. PubMed ID: 2795007 [Abstract] [Full Text] [Related]
52. In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system. Kilbourn MR. Life Sci; 1988 Nov 12; 42(14):1347-53. PubMed ID: 3352457 [Abstract] [Full Text] [Related]
53. Kinetic evaluation of the commonality between the site(s) of action of cocaine and some other structurally similar and dissimilar inhibitors of the striatal transporter for dopamine. Meiergerd SM, Schenk JO. J Neurochem; 1994 Nov 12; 63(5):1683-92. PubMed ID: 7931324 [Abstract] [Full Text] [Related]
54. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats. Masserano JM, Venable D, Wyatt RJ. J Pharmacol Exp Ther; 1994 Jul 12; 270(1):133-41. PubMed ID: 8035309 [Abstract] [Full Text] [Related]
55. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier. Héron C, Billaud G, Costentin J, Bonnet JJ. Eur J Pharmacol; 1996 Apr 22; 301(1-3):195-202. PubMed ID: 8773464 [Abstract] [Full Text] [Related]
56. Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex. Ikegami H, Prasad C. Peptides; 1990 Apr 22; 11(1):145-8. PubMed ID: 2342989 [Abstract] [Full Text] [Related]
57. In vivo voltammetric characterization of low affinity striatal dopamine uptake: drug inhibition profile and relation to dopaminergic innervation density. Stamford JA, Kruk ZL, Millar J. Brain Res; 1986 May 14; 373(1-2):85-91. PubMed ID: 3487373 [Abstract] [Full Text] [Related]
58. Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine. Debler EA, Hashim A, Lajtha A, Sershen H. Life Sci; 1988 May 14; 42(25):2553-9. PubMed ID: 3260319 [Abstract] [Full Text] [Related]